Sign in
4

Changes in Ownership

HALOZYME THERAPEUTICS, INC. Filed Acc 0001179110-21-008665

President and CEO sold 50,000 shares at an average $42.38 ($2,118,846)

  • President and CEO acquired 50,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Torley Helen · President and CEO

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2021-09-07 Exercise or conversion : show line 1 in the form +50,000 $14.66 $733,000 587,160 D
2021-09-07 Sale : show line 2 in the form −43,440 $42.29 $1,836,904 543,720 D
2021-09-07 Sale : show line 3 in the form −6,560 $42.98 $281,942 537,160 D
Open-market sales · 50,000 sh · avg $42.38 · $2,118,846

Table II: Derivative

1 line
Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
2021-09-07 Exercise or conversion : show line 4 in the form Option to Purchase Common Stock −50,000 $14.66 $733,000 $14.66 2024-01-06 50,000 250,000 D
Loading xslF345X03/edgar.xml…